Central Clinical Hospital with Outpatient Health Center of Business Administration for the President of Russian Federati Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2007
NCT00997750
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

lornoxicam (1 trial)

Drugs in Phase 2 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Contracture (Phase 2)

Hyperplasia (Phase 2)

Prostatic Hyperplasia (Phase 2)

Syndrome (Phase 4)

Torticollis (Phase 2)

Urinary Bladder Neck Obstruction (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2